390 related articles for article (PubMed ID: 36016154)
1. COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic.
Chandley P; Subba P; Rohatgi S
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016154
[TBL] [Abstract][Full Text] [Related]
2. Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications.
Gurunathan S; Lee AR; Kim JH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293381
[TBL] [Abstract][Full Text] [Related]
3. Antibody Responses and CNS Pathophysiology of Mucormycosis in Chronic SARS Cov-2 Infection: Current Therapies Against Mucormycosis.
Beeraka NM; Liu J; Sukocheva O; Sinelnikov MY; Fan R
Curr Med Chem; 2022; 29(32):5348-5357. PubMed ID: 35538800
[TBL] [Abstract][Full Text] [Related]
4. Review on Mucormycosis: Pathogenesis, Epidemiology, Microbiology and Diagnosis.
Sharma A; Alam MA; Dhoundiyal S; Sharma PK
Infect Disord Drug Targets; 2024; 24(1):e220823220209. PubMed ID: 37608614
[TBL] [Abstract][Full Text] [Related]
5. Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis.
García-Carnero LC; Mora-Montes HM
J Fungi (Basel); 2022 Apr; 8(5):. PubMed ID: 35628701
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 associated mucormycosis surge: A review on multi-pathway mechanisms.
Pourazizi M; Hakamifard A; Peyman A; Mohammadi R; Dehghani S; Tavousi N; Hosseini NS; Azhdari Tehrani H; Abtahi-Naeini B
Parasite Immunol; 2024 Jan; 46(1):e13016. PubMed ID: 37846902
[TBL] [Abstract][Full Text] [Related]
7. Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis.
Prakash H; Skiada A; Paul RA; Chakrabarti A; Rudramurthy SM
J Fungi (Basel); 2021 Jul; 7(8):. PubMed ID: 34436155
[TBL] [Abstract][Full Text] [Related]
8. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
9. Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread.
Dogra S; Arora A; Aggarwal A; Passi G; Sharma A; Singh G; Barnwal RP
Front Microbiol; 2021; 12():794176. PubMed ID: 35058909
[TBL] [Abstract][Full Text] [Related]
10. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.
Kamrul-Hasan AB; Selim S
Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483
[TBL] [Abstract][Full Text] [Related]
11. Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients.
Monika P; Chandraprabha MN
Mol Biol Rep; 2022 Jun; 49(6):4977-4988. PubMed ID: 35107737
[TBL] [Abstract][Full Text] [Related]
12. Genetic Manipulation in Mucorales and New Developments to Study Mucormycosis.
Lax C; Cánovas-Márquez JT; Tahiri G; Navarro E; Garre V; Nicolás FE
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408814
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
[TBL] [Abstract][Full Text] [Related]
14. The potential for rapid antigen testing for mucormycosis in the context of COVID-19.
Thornton CR
Expert Rev Mol Diagn; 2024 Mar; 24(3):161-167. PubMed ID: 37405409
[TBL] [Abstract][Full Text] [Related]
15. Antifungal combinations in Mucorales: A microbiological perspective.
Schwarz P; Cornely OA; Dannaoui E
Mycoses; 2019 Sep; 62(9):746-760. PubMed ID: 30830980
[TBL] [Abstract][Full Text] [Related]
16. Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets - Magnifying global pandemic grieve and catastrophe begins.
Pushparaj K; Kuchi Bhotla H; Arumugam VA; Pappusamy M; Easwaran M; Liu WC; Issara U; Rengasamy KRR; Meyyazhagan A; Balasubramanian B
Sci Total Environ; 2022 Jan; 805():150355. PubMed ID: 34818767
[TBL] [Abstract][Full Text] [Related]
17. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management.
Rudrabhatla PK; Reghukumar A; Thomas SV
Acta Neurol Belg; 2022 Apr; 122(2):273-280. PubMed ID: 34820787
[TBL] [Abstract][Full Text] [Related]
18. Mucormycosis in India: Pathophysiology and Perspectives on Treatment and Management.
Gupta U; Paliwal D; Rawat S
Infect Disord Drug Targets; 2022; 22(7):67-75. PubMed ID: 35532252
[TBL] [Abstract][Full Text] [Related]
19. How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection?
Lugito NPH; Cucunawangsih C
Mycopathologia; 2021 Dec; 186(6):877-882. PubMed ID: 34623597
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 associated mucormycosis - An emerging threat.
Chao CM; Lai CC; Yu WL
J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
